SCHEMBL823668

SCHEMBL823668

CCOc1nc(N)nc2ccc(-c3cccc(NS(=O)(=O)c4cnc(NC(C)=O)s4)c3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
PIK3CA P42336 4/20 0.42
MTOR P42345 3/20 0.42
AKT1 P31749 2/20 0.42
DHFR P00374 1/20 0.39
ATR Q13535 1/20 0.38
HSPA5 P11021 1/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
S1PR1 P21453 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
RECQL P46063 1/20 0.37
PIK3CG P48736 2/20 0.37
JAK2 O60674 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 1/20 0.36
STAT1 P42224 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823645 0.81 DHFR (0.48) MAPTDHFRATRLMNAPOLB
SCHEMBL823663 0.81 DHFR (0.54) MAPTDHFRATRLMNAPOLB
SCHEMBL823707 0.79 MAPT (0.51) MAPTDHFRLMNAPOLBHPGD
SCHEMBL823634 0.77 KDM1A (0.46) MAPTAKT1DHFRATRLMNA
SCHEMBL823669 0.77 SYK (0.43) MAPTDHFRLMNAPOLBMAPK1
SCHEMBL823636 0.76 DHFR (0.45) MAPTDHFRLMNAPOLBMAPK1
SCHEMBL823659 0.75 DHFR (0.44) MAPTDHFRLMNAPOLBHPGD
SCHEMBL823710 0.75 NR3C2 (0.48) MAPTAKT1DHFRLMNAPOLB
SCHEMBL4522465 0.74 MEN1 (0.46) MAPTPIK3CAAKT1LMNAPOLB
SCHEMBL4414487 0.72 MAP4K4 (0.45) PIK3CADHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US claimed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
WO-2008077649-A1 PYRIDO(3,2-D)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTONS GILEAD SCIENCES, INC. (US) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS PNPO, DPYD, PLPBP MAPT 2803/4885PIK3CA 1189/4885MTOR 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.